|
9C7W
human OC43 Main Protease (1-303) in complex with potent inhibitor
Deposited 2024-06-11
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
3247–3544(298 aa)
|
Mutation:P3460L
|
A1AUY (8S)-3-(4,4-difluorocyclohexyl)-5-(pyrimidin-2-yl)pyrazolo[1,5-a]pyrimidine × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;291 K;0.1M HEPES pH 7.5, 8% EG, 10% PEG 8K
|
Resolution 2.08 Å
R-free 0.246
|
|
9C7W
human OC43 Main Protease (1-303) in complex with potent inhibitor
Deposited 2024-06-11
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
3247–3544(298 aa)
|
Mutation:P3460L
|
A1AUY (8S)-3-(4,4-difluorocyclohexyl)-5-(pyrimidin-2-yl)pyrazolo[1,5-a]pyrimidine × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;291 K;0.1M HEPES pH 7.5, 8% EG, 10% PEG 8K
|
Resolution 2.08 Å
R-free 0.246
|
|
9C7W
human OC43 Main Protease (1-303) in complex with potent inhibitor
Deposited 2024-06-11
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain C
3247–3544(298 aa)
|
Mutation:P3460L
|
A1AUY (8S)-3-(4,4-difluorocyclohexyl)-5-(pyrimidin-2-yl)pyrazolo[1,5-a]pyrimidine × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;291 K;0.1M HEPES pH 7.5, 8% EG, 10% PEG 8K
|
Resolution 2.08 Å
R-free 0.246
|
|
9C7W
human OC43 Main Protease (1-303) in complex with potent inhibitor
Deposited 2024-06-11
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain D
3247–3544(298 aa)
|
Mutation:P3460L
|
A1AUY (8S)-3-(4,4-difluorocyclohexyl)-5-(pyrimidin-2-yl)pyrazolo[1,5-a]pyrimidine × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;291 K;0.1M HEPES pH 7.5, 8% EG, 10% PEG 8K
|
Resolution 2.08 Å
R-free 0.246
|
|
9PAE
Crystal structure of HCoV OC43 3CLpro with ALG-097608 (inhibitor 1)
Deposited 2025-06-25
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
3247–3549(303 aa)
Chain B
3247–3549(303 aa)
|
Not recorded
|
A1CHF (1R,2R,3S,6S,7S)-4-[(2S)-3,3-dimethyl-2-(2,2,2-trifluoroacetamido)butanoyl]-10,10-difluoro-N-{(1E,2R)-1-imino-3-[(3R)-2-oxo-3,4-dihydro-2H-pyrrol-3-yl]propan-2-yl}-4-azatricyclo[5.2.1.0~2,6~]decane-3-carboxamide (non-preferred name) × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;277 K;0.2M Potassium thiocyanate, 0.1 M Bis-Tris pH 8.5 and 20% PEG3350
|
Resolution 2.31 Å
R-free 0.280
|
|
9PAE
Crystal structure of HCoV OC43 3CLpro with ALG-097608 (inhibitor 1)
Deposited 2025-06-25
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain C
3247–3549(303 aa)
Chain D
3247–3549(303 aa)
|
Not recorded
|
A1CHF (1R,2R,3S,6S,7S)-4-[(2S)-3,3-dimethyl-2-(2,2,2-trifluoroacetamido)butanoyl]-10,10-difluoro-N-{(1E,2R)-1-imino-3-[(3R)-2-oxo-3,4-dihydro-2H-pyrrol-3-yl]propan-2-yl}-4-azatricyclo[5.2.1.0~2,6~]decane-3-carboxamide (non-preferred name) × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;277 K;0.2M Potassium thiocyanate, 0.1 M Bis-Tris pH 8.5 and 20% PEG3350
|
Resolution 2.31 Å
R-free 0.280
|